News & Perspective

Jul 05, 2006

Jul 05, 2006

HHS has enough H5N1 vaccine for 4 million people

(CIDRAP News) – In an update on pandemic influenza preparedness efforts, the federal government said last week it had stockpiled enough vaccine against H5N1 avian influenza virus to inoculate about 4 million people and enough antiviral medication to treat about 6.3 million.

Oct 04, 2006

Oct 04, 2006

Groups call for pandemic flu vaccine 'master plan'

(CIDRAP News) – Public health and infectious disease experts today called on the United States to develop a "master plan" for development of pandemic influenza vaccines in order to translate scientific advances more rapidly into improved pandemic preparedness.

Nov 15, 2006

Nov 15, 2006

'Gene chip' test could speed H5N1 diagnosis

(CIDRAP News) – Scientists say they have developed an inexpensive "gene chip" test that can quickly identify a variety of influenza A viruses, including H5N1, and is less apt to be confused by viral mutations than other tests are.

Dec 29, 2006

Dec 29, 2006

Feds detail progress on pandemic preparedness

(CIDRAP News) – In a recent update on pandemic influenza preparedness planning, the US government reported meeting more than 90% of a long list of objectives it set for itself about 6 months ago.

The report charts progress on a wide range of preparedness measures, from shoring up laboratory capabilities to planning for distribution of critical medical supplies and preparing checklists for various sectors of the economy.

May 03, 2007

May 03, 2007

CDC offers advice on citizen use of masks, respirators

(CIDRAP News) – Though there is little scientific evidence to go on, wearing a surgical face mask may make sense for people who have to go into crowded public places during an influenza pandemic, federal health officials said today.

May 09, 2007

May 09, 2007

FDA lists 2 respirators as offering disease protection

(CIDRAP News) – The US Food and Drug Administration (FDA) yesterday cleared the way for two N-95 respirator models to be marketed as devices that can reduce a user's risk of becoming ill during an influenza pandemic or other public health emergency.

Aug 27, 2007

Aug 27, 2007

Trial results for Glaxo's H5N1 vaccine released

(CIDRAP News) – The full results of a trial of GlaxoSmithKline's (GSK's) H5N1 influenza vaccine were released recently, showing that the vaccine in combination with an adjuvant produced an acceptable immune response at a low dose and may provide cross-protection against nonmatching H5N1 strains.

Sep 26, 2007

Sep 26, 2007

IOM calls for new research on safety garb for health workers

(CIDRAP News) – An Institute of Medicine (IOM) committee that studied issues concerning personal protective equipment (PPE) for healthcare workers in an influenza pandemic is calling for renewed efforts to learn how influenza viruses spread, promote proper use of PPE, and improve the equipment itself.

Nov 15, 2007

Nov 15, 2007

THE PANDEMIC VACCINE PUZZLE Can we vaccinate enough people in time to matter?

Maryn McKennaContributing Writer

(CIDRAP News) – This in-depth article investigates the prospects for development of vaccines to head off the threat of an influenza pandemic posed by the H5N1 avian influenza virus. Its seven parts put advances in vaccine technology in perspective by illuminating the formidable barriers to producing an effective and widely usable vaccine in a short time frame.

Dec 18, 2007

Dec 18, 2007

Funding cuts said to threaten states' preparedness progress

(CIDRAP News) – Several states have made progress preparing for a major public health emergency such as a pandemic or bioterror attack, but funding shortfalls at the federal level threaten to stall or even reverse recent gains, according to a report today from the nonprofit organization Trust for America's Health (TFAH).

Pages

by organization

Newsletter Sign-up

Get CIDRAP news and other free newsletters.

Sign up now»

OUR UNDERWRITERS

Unrestricted financial support provided by

Bentson Foundation Gilead 
Grant support for ASP provided by


bioMérieux

  Become an underwriter»